Cancer multidrug resistance (MDR): a major impediment to effective chemotherapy
- PMID: 18439063
Cancer multidrug resistance (MDR): a major impediment to effective chemotherapy
Abstract
Multidrug resistance (MDR) continues to be a major challenge to effective chemotherapeutic interventions against cancer. Various types of cancers have been observed to exhibit this phenomenon, a strategy that involves cellular and non cellular mechanisms employed by cancer cells to survive the cytotoxic actions of various structurally and functionally unrelated drugs. The present article is a brief review of the fundamental mechanisms underlying the phenomenon of MDR in cancer cells and some novel approaches addressed at its inhibition, circumvention or reversal. The emergence of natural products as potential anti-MDR molecules is of particular significance. Since many of these are essential components of the human diet, they are expected to possess fewer side effects and may possibly represent a new generation of MDR modulators.
Similar articles
-
New Approaches With Natural Product Drugs for Overcoming Multidrug Resistance in Cancer.Curr Pharm Des. 2015;21(38):5589-604. doi: 10.2174/1381612821666151002113546. Curr Pharm Des. 2015. PMID: 26429711 Review.
-
Multidrug resistance: clinical relevance in solid tumours and strategies for circumvention.Curr Opin Oncol. 1998 Aug;10 Suppl 1:S15-9. Curr Opin Oncol. 1998. PMID: 9801854 Review.
-
Nanoplatform-based natural products co-delivery system to surmount cancer multidrug-resistant.J Control Release. 2021 Aug 10;336:396-409. doi: 10.1016/j.jconrel.2021.06.034. Epub 2021 Jun 25. J Control Release. 2021. PMID: 34175367 Review.
-
Cancer multidrug resistance: mechanisms involved and strategies for circumvention using a drug delivery system.Arch Pharm Res. 2014 Jan;37(1):4-15. doi: 10.1007/s12272-013-0276-2. Epub 2013 Nov 23. Arch Pharm Res. 2014. PMID: 24272889 Review.
-
Mechanisms of chemotherapeutic drug resistance in cancer therapy--a quick review.Taiwan J Obstet Gynecol. 2009 Sep;48(3):239-44. doi: 10.1016/S1028-4559(09)60296-5. Taiwan J Obstet Gynecol. 2009. PMID: 19797012 Review.
Cited by
-
Targeting p53 for Melanoma Treatment: Counteracting Tumour Proliferation, Dissemination and Therapeutic Resistance.Cancers (Basel). 2021 Apr 1;13(7):1648. doi: 10.3390/cancers13071648. Cancers (Basel). 2021. PMID: 33916029 Free PMC article.
-
Clinical development and potential of photothermal and photodynamic therapies for cancer.Nat Rev Clin Oncol. 2020 Nov;17(11):657-674. doi: 10.1038/s41571-020-0410-2. Epub 2020 Jul 22. Nat Rev Clin Oncol. 2020. PMID: 32699309 Review.
-
A microfluidic system to study the cytotoxic effect of drugs: the combined effect of celecoxib and 5-fluorouracil on normal and cancer cells.Mikrochim Acta. 2013 Jul;180(9-10):895-901. doi: 10.1007/s00604-013-1009-4. Epub 2013 May 21. Mikrochim Acta. 2013. PMID: 23805007 Free PMC article.
-
Chemotherapy and Physical Therapeutics Modulate Antigens on Cancer Cells.Front Immunol. 2022 Jul 6;13:889950. doi: 10.3389/fimmu.2022.889950. eCollection 2022. Front Immunol. 2022. PMID: 35874714 Free PMC article. Review.
-
Identified the novel resistant biomarkers for taxane-based therapy for triple-negative breast cancer.Int J Med Sci. 2021 Apr 26;18(12):2521-2531. doi: 10.7150/ijms.59177. eCollection 2021. Int J Med Sci. 2021. PMID: 34104083 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources